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Cobalt Chloride Pretreatment Promotes Cardiac
Differentiation of Human Embryonic Stem Cells
Under Atmospheric Oxygen Level
*Kwong-Man Ng,1–3 *Yau-Chi Chan,3 Yee-Ki Lee,3 Wing-Hon Lai,3 Ka-Wing Au,3 Man-Lung Fung,1,2
Chung-Wah Siu,1,3 Ronald A. Li,1–4 and Hung-Fat Tse1,3,4
Abstract
Our previous study demonstrated the direct involvement of the HIF-1a subunit in the promotion of cardiac
differentiation of murine embryonic stem cells (ESCs). We report the use of cobalt chloride to induce HIF-1a
stabilization in human ESCs to promote cardiac differentiation. Treatment of undifferentiated hES2 human ESCs
with 50 lM cobalt chloride markedly increased protein levels of the HIF-1a subunit, and was associated with
increased expression of early cardiac specific transcription factors and cardiotrophic factors including NK2.5,
vascular endothelial growth factor, and cardiotrophin-1. When pretreated cells were subjected to cardiac dif-
ferentiation, a notable increase in the occurrence of beating embryoid bodies and sarcomeric actinin-positive cells
was observed, along with increased expression of the cardiac-specific markers, MHC-A, MHC-B, and MLC2V.
Electrophysiological study revealed increased atrial- and nodal-like cells in the cobalt chloride-pretreated group.
Confocal calcium imaging analysis indicated that the maximum upstroke and decay velocities were significantly
increased in both noncaffeine and caffeine-induced calcium transient in cardiomyocytes derived from the cobalt
chloride-pretreated cells, suggesting these cells were functionally more mature. In conclusion, our study dem-
onstrated that cobalt chloride pretreatment of hES2 human ESCs promotes cardiac differentiation and the
maturation of calcium homeostasis of cardiomyocytes derived from ESCs.
Introduction
Human embryonic stem cells (ESCs), derived from theinner cell mass of blastocysts, can self-renew while
maintaining their pluripotency to become all cell types in-
cluding highly specialized and terminally differentiated cells
such as cardiomyocytes (Moore et al., 2005; Siu et al., 2007).
Successful differentiation of cardiomyocytes from human
ESCs represents an important step in the development of
cardiovascular regenerativemedicine. The clinical application
of human ESC-derived cardiomyocytes nonetheless remains
questionable due to the extremely low tendency of sponta-
neous cardiac differentiation from cultured human ESCs as
well as the immaturity of the differentiated cardiomyocytes.
Previous studies have demonstrated that low oxygen tension
or hypoxia plays an important role in the proliferation, dif-
ferentiation, and maintenance of the cardiovascular system
during embryonic development (Fisher and Burggren, 2007;
Huang et al., 2004; Ramirez-Bergeron et al., 2004; Simon and
Keith, 2008; Xue and Tomanek, 1999). Although reduced
oxygen tension appears to direct cultured ESCs to differentiate
into cardiomyocytes (Niebruegge et al., 2009), the underlying
molecular mechanism remains unclear. At a cellular level, the
handling of a hypoxia signal involves the hypoxia induc-
ible factor 1 (HIF-1), a transcription factor that consists of an
oxygen labile alpha subunit (HIF-1a) and an oxygen inert beta
subunit (HIF-1b) (Wang et al., 1995). Our recent study dem-
onstrated that direct increased HIF-1a expression via gene
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transfer promotes cardiac differentiation and maturation of
cultured mouse ESCs (Ng et al., 2010). These findings suggest
that HIF-1amay enhance cardiac differentiation of ESCs. The
therapeutic application of HIF-1a gene transfer to promote
cardiomyocyte differentiation of ESCs is nevertheless limited
by the use of a viral vector. A virus-free method that can
increase the HIF-1a expression would thus be preferable.
The effects of direct reduced-oxygen treatment on cardiac
differentiation of human ESCs are inconsistent and non-
reproducible. Ezashi et al. (2005) showed that reduced oxy-
gen tension prevents differentiation of human ESCs. On the
other hand, Chen et al. (2009) demonstrated that 5% oxygen
culture is not beneficial for the maintenance of human ESCs
in an undifferentiated state with short splitting intervals.
Despite the fact that reduced oxygen treatment may enhance
cardiac differentiation of ESCs (Niebruegge et al., 2009), the
number of consequent viable cardiomyocytes may be limited
by poor cell survival during prolonged culture with reduced
oxygen tension treatment (Ng et al., 2010). Other methods
such as pharmacological treatment with divalent ions such
as cobalt (II) and nickel (II) ions (Bunn and Poyton, 1996) to
stabilize the HIF-1a subunit may thus provide an attractive
alternative. In fact, cobalt chloride has been used in stabi-
lizing the HIF-1a in both cell culture and animal models in
various studies. For example, application of cobalt chloride
has been shows to increase the HIF-1a stability in acute
myeloid leukemic cells (Huang et al., 2003) as well as human
nasal polyp fibroblasts (Lin et al., 2008), whereas short-term
cobalt administration caused HIF-1 in the kidney tubules in a
rat model (Matsumoto et al., 2003). The exact reason ac-
counted for hypoxia mimicking property of cobalt chloride
remains inconclusive. Because the degradation of HIF-1a
requires prolyl hydroxalation and such process utilizes iron
ion as cofactor, it is likely that cobalt chloride increases the
HIF-1a stability via its iron antagonistic action (Kaelin, 2002;
Kivirikko and Myllyharju 1998).
In the present study, we sought to investigate the use of
cobalt chloride to stabilize the HIF-1a protein at normal ox-
ygen levels to enhance cardiac differentiation and matura-
tion of human ESCs. The results of this study provide new
insight in the development of a novel strategy to improve the
differentiation and functional property of cardiomyocytes
derived from human ESCs.
Materials and Methods
Maintenance and cardiac differentiation of hES2 cells
Human ESC, the hES2 line, was obtained from the WiCell
Research Institute (Madison, WI). The undifferentiated cells
were maintained in a serum- and feeder-free environment
using the StemPro hESC SFM system (Invitrogen, Carlsbad,
CA) according to the manufacture’s instruction. Where nec-
essary, hES2 cells (at 60% confluence) were treated with co-
balt chloride (at the final concentration of 50 lM) for 3 days
prior to cardiac differentiation. For cardiac differentiation,
when cells reached 80% confluence, cell colonies were treated
with dispase (1mg/mL) for 5min at 37C and scraped off
into small aggregates. The cell aggregates were allowed to
become embryoid bodies (EB) by being cultured in suspension
in the StemPro hESC medium for 5 days. After suspension,
EBs were plated onto a gelatin-coated plate in a basal medium
[StemPro34, Invitrogen, containing 2mM glutamine, 4mM
monothioglycerol (MTG), 50lg/mL ascorbic acid, and
0.5ng/mL bone morphogenetic protein-4 [BMP4]) according
to previous protocol (Yang et al., 2008). The following con-
centrations of factors were used for primitive-streak formation
and for mesoderm induction for cardiac differentiation: BMP4,
10ng/mL; human basic fibroblast growth factor (bFGF), 5 ng/
mL; activin A, 3 ng mL- 1, and human DKK1, 150ng/mL.
Factors were added as follows: days 1–4, BMP4, bFGF, and
activin A; days 4–8, DKK1; after day 8, DKK1 and bFGF. The
bFGF was purchased from Peprotech (Rockyhill, NJ), DKK1
from Gibco (Grand Island, NY). and activin-A from Stemgent
(San Diego, CA).
Western blot analysis
The total proteins from hES2 cells were isolated as de-
scribed previously (Ng et al., 2010, 2011). Fifty micrograms of
total soluble protein was resolved on 10% PAGE and trans-
ferred onto a PVDF membrane electrically. After incubating
in the blocking solution (1·Tris-buffered saline, 0.05%
Tween-20, 5% nonfat powdered milk), the membrane was
incubated with the primary antibody as indicated in the
figure at 4C for 16 h. Unbound antibodies were removed by
three washes in washing buffer (1 ·Tris-buffered saline,
0.05% Tween-20), and the membrane incubated with an
HRP-conjugated antimouse IgG secondary antibody (GE
Healthcare, Piscataway, NJ) at room temperature for 1 h.
Free antibodies were removed by three washes in washing
buffer, and the presence of the protein–antibody complex
was visualized using the ECL Plus Western blotting detec-
tion reagents (GE Healthcare).
End-stage PCR and real-time quantitative
PCR analysis
Total RNA was isolated and reverse transcribed using
the illustra RNAspin Mini Kit (GE Healthcare): 0.5 lg was
reverse-transcribed into first-strand cDNA using the Quan-
tiTect Rev. Transcription Kit (Qiagen, Chatsworth, CA).
Table 1. Primers Used for RT-PCR
Gene Direction Sequence (5† to 3¢)
HIF-1a Forward TGATGACCAGCAACTTGAGG
Reverse GCGGAACTGCTTTCTAATGG
HIF-2a Forward TGGATTTCGGGAATCAGAAC
Reverse CTGCTGCTGAAACTTGTCCA
HIF-3a Forward TGGCTATAGTCCCGATGACC
Reverse GGGAGTGGCTGCTACTGAAG
HIF-1b Forward CAAGCCCCTTGAGAAGTCAG
Reverse TCTGTCCAGTCTCAGGAGCA
HIF-2a Forward TGAAGAAGACGCTGATGTGG
Reverse GGGGACCTGGGATAAGTCAT
EGLN2 Forward GTACTACGGCATCTGCGTCA
Reverse CCGGTCAGACCAGAAAATGA
EGLN1 Forward GGCCAAGGGAAAAGTAAAGG
Reverse TTCCCGTTACAGTGGCGTAT
EGLN3 Forward AATTGCCCTGGAGTACATCG
Reverse ACTTCGTGTGGGTTCCTACG
PH-4 Forward GTGACGGAGTGCTGAGTCTG
Reverse CCCATCAGGCAGGTAGTTGT
FIH Forward AGAATGAGGAGCCTGTGGTG
Reverse GGGTGATGAACAGGGTATGG
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Expression of the genes of interest was evaluated by end-
stage or real-time quantitative amplification using 0.2 lL of
the cDNA as a template using the respective oligonucleo-
tides (see Tables 1 and 2). Quantitative PCR analysis was
performed with DNA engine opticon 2 real-time PCR De-
tection System (Bio-Rad, Hercules, CA) using the iQ SYBR
Green Supermix (Bio-Rad). For amplification, after initial
holds for 5min at 50C, 50 cycles of 95C for 15 sec, followed
by 57C for 30 sec and 72C for 30 sec, melt curve analysis
was performed. The relative quantification of the PCR
products was performed according to the 2 -DDCt method,
using ribosomal protein S16 (S16) as internal control. Where
DDCt= [(Cttarget gene - CtS16)CoCl2 treated group - (Cttarget gene -
CtS16) control group]].
Flow cytometry analysis
The percentage of ESC-derived cardiomyoyctes was quan-
tified by FACS analysis. Briefly, EBs were dissociated with
1mg/mL collagenase B (Roche Applied Sciences, Penzberg,
German), washed with differentiated medium, and the cells
permeabilized by Cytofix/Cytoperm permeabilization kit (BD
Biosciences, San Diego, CA). Cells were then stained with
monoclonal antisarcomeric actinin antibody (A7811, Sigma,
St. Louis, MO) using antimouse IgG H+L-PE as a secondary
antibody stain (Beckman Coulter, Fullerton, CA). Analysis
was performed with a Beckman Coulter FC500 flow cyt-
ometer in which at least 1000 events were counted.
Isolation of hES2-derived cardiomyocytes
Isolation of hES2-derived cardiomyocytes has beendescribed
previously (Auet al., 2009; Lieu et al., 2009; Liu et al., 2007, 2009).
Briefly, beatingoutgrowthsweremicrosurgicallydissected from
hES2-derived EBs (25 days) with a glass knife, followed by in-
cubation in collagenase B (1mg/mL, Roche Applied Sciences)
with DNase I (60U/mL, Roche Applied Sciences) at 37C for
30min with occasional rocking. Isolated cells were recovered in
Kraftbru¨he (KB) solution containing (mM) 85KCl, 30K2HPO4, 5
MgSO4, 1 EGTA, 2 Na2-ATP, 5 pyruvic acid, 5 creatine, 20 tau-
rine, and 20 D-glucose at room temperature for 1h. The cells
were subsequently plated on 0.1% gelatin coated glass cover
slips in 24-well cultureplateswith correspondingdifferentiation
medium. Immunohistochemistry, electrophysiological study,
and confocal calcium imaging of isolated cells or cell clusters
were performed within 2 days.
Immunohistochemistry
The hES2-derived cardiomyocytes were fixed with 2%
paraformaldehyde for 15min at 4C followed by two washes
with phosphate-buffered saline (PBS). Prior to overnight incu-
bation with murine monoclonal anticardiac Troponin-T anti-
body (NeoMarker, Fremont, CA)ormonoclonal antisarcomeric
actinin antibody (A7811, Sigma) at 4C,fixed cellswereblocked
in 2%bovine serumalubmin (BSA), PBS, and 0.1%TritonX-100
for 2 h. After removal of unbound antibodies with washing
buffer, cells were incubated with Alexa-488 conjugated anti-
mouse secondary antibodies (Invitrogen, Carlsbad, CA) (1:100
dilution in washing buffer) for 1 h at room temperature. Cells
were then mounted on glass slides with a mounting medium
containing DAPI. The presence of the immune complex was
examined by fluorescent microscopy.
Electrophysiological study
For electrophysiological characterization of hES2-derived
cardiomyocytes, the standard whole-cell patch-clamp re-
cording was performed at 37 – 0.5C to record the action
potential phenotypes (HEKA Instruments Inc., Southboro,
MA) as previously described (Chan et al., 2009). In brief,
patch pipettes were prepared from 1.5-mm thin-walled bo-
rosilicate glass tubes using a Sutter micropipette puller P-97
and had typical resistances of 3–4MO when filled with an
Table 2. Primers Used for Real-Time
Quantitative RT-PCR
Gene Direction Sequence (5¢ to 3¢)
HIF-1a Forward TGCATCTCCATCTCCTACCC
Reverse CGTTAGGGCTTCTTGGATGA
GATA4 Forward GATCTTCGCGACAGTTCCTC
Reverse CATGGCCAAGCTCTGATACA
Nkx2.5 Forward TTCCCGCCGCCCCCGCCTTCTAT
Reverse CGCTCCGCGTTGTCCGCCTCTGT
VEGF Forward CCTTGCTGCTCTACCTCCAC
Reverse CACACAGGATGGCTTGAAGA
CTF-1 Forward GGAGGGAAGTCTGGAAGACC
Reverse CTGCACATATTCCTGGAGCA
NGN Forward AGTGACCTATCCGGCTTCC
Reverse AGACGCCCGGGAGATATTG
MYOG Forward GTGGGCGTGTAAGGTGTGTA
Reverse AGCAGGGTGCTTCTCTTCAG
GATA1 Forward ACTGCCCATCTCTACCAAGG
Reverse CCACAGTAGTGCTGGTGGTG
SPI1 Forward AAGAAGATCCGCCTGTACCA
Reverse TTGTGCTTGGACGAGAACTG
OCT4 Forward ACATCAAAGCTCTGCAGAAA
GAACT
Reverse CTGAATACCTTCCCAAATAGA
ACCC
SOX2 Forward AACCCCAAGATGCACAACTC
Reverse GCTTAGCCTCGTCGATGAAC
NANOG Forward CAGCTGTGTGTACTCAATGA
TAGATTT
Reverse CAACTGGCCGAAGAATAGCA
ATGGTGT
MHC-A Forward GATGCCCAGATGGCTGACTT
Reverse GGTCAGCATGGCCATGTCCT
MHC-B Forward TGCAAAGGCTCCAGGTCTGA
GGGC
Reverse GCCAACACCAACCTGTCCAA
GTTC
MLC2V Forward GACCCAGATCCAGGAGTTCA
Reverse AATTGGACCTGGAGCCTCTT
NCX1 Forward TGTGCATCTCAGCAATGTCA
Reverse TGATGCCAATGCTCTCACTC
SERCA2A Forward ACCCACATTCGAGTTGGAAG
Reverse CAGTGGGTTGTCATGAGTGG
RYR2 Forward CGTTCTAACCAGCATCTCATC
Reverse CGAGCAATACAACCTGACC
CaSQ Forward GAGCTTGTGGCCCAGGTCCT
Reverse GATCTCCACTGGGTCTTCAA
Triadin Forward TCAGTTGCTCCACACTGAGC
Reverse CCCATTTACAGACGGGAAAC
Junctin Forward GTAAAATGGCATCCCGAGAC
Reverse GGATGATGATGCCAGAGC
S16 Forward AAGCCCTGGTGGCCTATTAC
Reverse CCAAACTTTTTGGACTCGCAGCG
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internal solution containing (mM): 110 K+ aspartate, 20 KCl,
1 MgCl2, 0.1 Na-GTP, 5 Mg-ATP, 5 Na2-phosphocreatine,
5 EGTA, 10 HEPES, and pH adjusted to 7.3 with KOH. The
external Tyrode’s bath solution consisted of (mM): 140 NaCl,
5 KCl, 1 MgCl2, 0.4 KH2PO4, 1.8 CaCl2, 10 Glucose, 5 HEPES,
with pH adjusted to 7.4 with NaOH. For those hES2-derived
cardiomyocytes that were electrically quiescent, a stimula-
tion of 0.1–1 nA for 5msec was given to elicit an action po-
tential. The sampling frequency was 2.00 kHz, and data were
corrected for the liquid junction potentials of + 20.3mV.
Confocal calcium imaging
Confocal calcium imaging was performed with the pro-
tocol described previously (Ng et al., 2010, 2011). In brief, the
isolated hES2-derived cardiomyocytes were loaded with
5 lM Fluo-3 AM (Invitrogen) for 25min at 37C in Tyrode
solution containing 140mM NaCl, 5mM KCl, 1mM MgCl2,
1.8mM CaCl2, 10mM glucose, and 10mM HEPES at pH 7.4.
Spontaneous calcium transient of single or clusters of ESC-
derived cardiomyocytes was recorded with a confocal im-
aging system (Olympus Fluoview System version 4.2 FV300
TIEMPO) mounted on an upright Olympus microscope
(IX71). To record the caffeine-induced calcium transient, 20lL
of 10mM caffeine was applied onto the cell surface during
measurement. To evaluate the effect of ryanodine, spontane-
ous calcium transients were recorded before and after the in-
cubation (5min) of Tyrode solution containing 10lM
ryanodine. The calcium transient was quantified as the back-
ground subtracted fluorescence intensity changes normalized
to the background subtracted baseline fluorescence. Data were
fed into the Felix 32 (PTI) software for analysis.
Statistical analysis
Continuous variables are expressed as mean – SEM. Sta-
tistical comparisons were performed using a Student’s t-test.
Calculations were performed with GraphPad Prism 5
(GraphPad, LaJolla, CA). A p-value < 0.05 was considered
statistically significant.
Results
Cobalt chloride treatment increases the protein levels
of HIF-1a in hES2 human ESCs
To evaluate the possibility of using cobalt chloride to activate
the HIF-1 pathway in hES2 cells, expression of the HIF-1 path-
way components in undifferentiated hES2 cells was evaluated
using end-stage PCR analysis. As shown in Figure 1A, both HIF-
1a and HIF-1b subunits as well as HIF-2a were expressed after
cobalt chloride treatment but there was no detectable HIF-3a.
These findings suggest that cobalt chloride treatment activates
expression of the HIF-1a and HIF-2a signal in hES2 cells. The
expression of other components of the HIF-1 pathway, including
the prolyl hydroxylases termed oxoglutarate-dependent proline
4-hydroxylases, EGLN-1 to 3 were also observed.
Undifferentiated hES2 cells were then subjected to treat-
ment with cobalt chloride (50 lM) or reduced oxygen (5%
O2) followed by Western blot analysis to evaluate the protein
levels of HIF-1 a. As shown in Figure 1B, both 72 h of cobalt
chloride treatment and 24 h of reduced oxygen treatment
remarkably increased cell HIF-1a protein levels. Nonetheless,
the cell viability of the reduced oxygen-treated groups was
thus significantly reduced to about 50% (Fig. 1C). There was
no such reduction in cell viability in the control (21% O2) or
cobalt chloride-treated group (Fig. 1C) and no significant
differences in the mRNA levels of HIF-1a between the two
groups (Fig. 1D). This suggests that cobalt chloride prevents
the breakdown of HIF-1a protein rather than increasing the
gene expression of HIF-1a in the undifferentiated hES2 cells.
Cobalt chloride treatment initiates the differentiation
of undifferentiated hES2 cells
To evaluate the effects of cobalt chloride-induced HIF-1a
stabilization on initiating cardiac differentiation, cultured
FIG. 1. Effect of cobalt chloride on
undifferentiated hES2 ESCs. (A) The
expressions of the major components of
the hypoxia inducible factor 1-pathaway in
untreated undifferentiated hES2 stem cells
as revealed by end-stage PCR analysis. (B)
Undifferentiated hES2 cells were treated
with 50lM cobalt chloride (CoCl2) for 72 h
or cultured in 5% oxygen for 24h. After
treatment, the protein levels of HIF-1a
were determined by Western blot analysis
with HIF-1a specific antibody, while b-
actin protein levels were used as internal
control. (C) The viabilities of cells after
cobalt chloride or reduced oxygen
treatments were evaluated with Trypan
Blue dye exclusion assay. (D) The relative
mRNA levels of HIF-1a as revealed by
real-time quantitative PCR using S16 as
internal reference. Results are presented in
mean– SEM from at least three
independent experiments, where
**p< 0.005 compared to the control group,
and ##p< 0.005 compared to the cobalt
chloride-treated group.
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hES2 cells were harvested immediately following cobalt
chloride treatment, and the expression of early cardiac-
specific transcription factors [GATA-binding protein 4
(GATA4) and NK2 transcription factor related locus 5
(Nkx2.5)] and cardiotrophic factors [vascular endothelial
growth factor (VEGF) and cardiotrophin-1 (CT1)] were
compared with controls using quantitative real-time PCR
analysis. Cobalt chloride pretreatment significantly increased
mRNA levels of Nkx2.5 (1.8-fold, p< 0.05), VEGF (1.6-fold,
p < .05), and CT1 (4.3-fold, p< 0.005), but not GATA4 (Fig.
2A). Interestingly, in addition to the early cardiac markers,
the expression of the early neuronal marker, neurogenin1
(NGN) was also increased significantly (3.1-fold, p< 0.005)
upon cobalt chloride treatment, whereas those governing
the development of skeletal muscle (MYOG) and erythro-
poietin lineage (GATA1 and SPI1) did not show significant
changes (Fig. 2A).
On the other hand, the expressions of the pluripotency
markers, octamer-binding transcription factor 4 (OCT4), sex
determining region Y-box 2 (SOX2), and homeobox protein
NANOG (NANOG) were significantly reduced by 0.76-fold
( p< 0.005), 0.65 ( p < 0.05), and 0.38 ( p< 0.005), respectively,
after cobalt chloride treatment (Fig. 2B).
Cobalt chloride pretreatment facilitate the cardiac
differentiation of hES2 human ECSs
The control and cobalt chloride-pretreated cells were then
allowed to undergo cardiac differentiation. Comparison at
the 20th day after plating revealed that the percentage of
beating embryoid bodies (EBs) (Fig. 3A; p < 0.05) and sarco-
meric–actinin-positive cells (Fig. 3B; p< 0.005) was signifi-
cantly higher following cobalt chloride treatment. The
mRNA level of the cardiac specific genes, that is, myosin
heavy chain (MHC)-A (1.7-fold, p< 0.05); MHC-B (1.8-fold,
p< 0.05), and myosin light chain 2V (MLC2V) (1.5-fold,
p< 0.05) in the EBs differentiated from the cobalt-treated
hES2 cells was also significantly higher (Fig. 3C). Im-
munohistochemistry demonstrated that the cardiomyocytes
(cardiac troponin-T positive and sarcomeric–actinin-positive
cells) differentiated from the cobalt chloride-treated group
were generally more elongated (a significantly higher
length/width ratio) than those from the control group (Fig.
4A and B). At higher magnification, a more organized pat-
tern of myofibrils could be observed in the cobalt chloride-
pretreated group. These results suggest that cobalt chloride
pretreatment facilitates cardiac differentiation of the undif-
ferentiated hES2 cells.
Electrophysiology of hESC-derived cardiomyocytes
To test whether cobalt-induced cardiac differentiation in-
fluences the maturation of hES2-derived cardiomyocytes,
their electrophysiological properties were characterized by
whole-cell patch clamp experiments. Figure 5 depicts the
electrophysiogical characteristics (i.e., ventricular-like, atrial-
like, and nodal-like) and the corresponding representative
action potential recordings of cardiomyocytes derived from
the control and cobalt chloride-treated hES2. In the control
group, out of seven cells analyzed, 71% showed ventricular-
like phenotype and 29% exhibited the atrial-like phenotype
(Fig. 5A, left panel). Despite the limited number of cells being
studied, this observation is inline with the previous study
(Moore et al., 2008). In the cobalt chloride-pretreated group,
of 24 cardiomyocytes measured, 67%, 25%, and 8%, respec-
tively demonstrated atrial-, ventricular-, and nodal-like
phenotype (Fig. 5A, right panel). When the action potentials
at 90% (APD90s) and 50% (APD50s) repolarization of both
groups were compared, ventricular-like cells in particular
showed a decrease in both APD90s ( p< 0.05) and APD50s
( p < 0.01) on cardiomyocytes of the cobalt chloride-pretreated
group (Fig. 5B and C). In addition, maximum rise of the
action potential upstrokes (dV/dtmax) for cardiomyocytes
showing atrial- and ventricular-like phenotypes were both
significantly increased ( p < 0.05) (Fig. 5D). On the other hand,
the maximum diastolic potentials (MDPs) of both atrial-like
and ventricular-like cells showed no significant difference
between the two groups (Fig. 5E).
Cardiomyocytes differentiated from cobalt
chloride-pretreated cells exhibit improved
calcium-handling ability
Spontaneous intracellular calcium (Ca2 + ) transients in the
hES2-derived cardiomyocytes were assessed using confocal
laser microscopy 25 to 30 days following onset of beating. In
both control and cobalt chloride-pretreated groups, Ca2 +
FIG. 2. Cobalt chloride treatment increased the mRNA
levels of cardiogenic transcription factors, cardiotrophic fac-
tors, and neuronal transcription factor. (A) To evaluate the
action of cobalt chloride in initiating cardiac differentiation
of human ESCs, undifferentiated hES2 cell were cultured in
the presence or absence of 50 lM cobalt chloride (CoCl2), and
the expressions of GATA4, Nkx2.5, VEG, CT1, NGN, MYOG,
GATA1, and SPI1 were compared by quantitative real-time
PCR analysis using the ribosomal protein S16 as internal
reference. (B) The relative mRNA levels of OCT4, SOX2, and
NANOG as revealed by real-time quantitative PCR using
S16 as an internal reference. Results are presented in
mean– SEM from at least three independent experiments,
where *p< 0.05 and **p < 0.005 compared to the control
groups.
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flux was observed in their derived cardiomyocytes. Fluor-
escence intensity values measured against time revealed that
the amplitude of Ca2 + transient measured in cardiomyocytes
derived from the cobalt chloride-pretreated hES2 cells was
approximately 2.5-fold higher than that in the untreated
hES2-derived cardiomyocytes (Fig. 6A and B; p< 0.05). Si-
milarly, kinetic analysis revealed that cardiomyocytes de-
rived from cobalt chloride-pretreated hES2 cells displayed
faster calcium release and reuptake rates as indicated by the
significant increase in the upstroke (Vmaxupstroke) and decay
(Vmaxdecay) velocities (Fig. 6C and D; p < 0.05).
To evaluate the sarcoplasmic reticulum performance, the
caffeine-induced Ca2 + transient was also recorded. As
shown in Figure 6E, brief exposure to 10mM caffeine in-
duced a surge in cytosolic Ca2 + that subsequently decayed
back to baseline in the cardiomyocytes derived from both
control and cobalt chloride-pretreated hES2 cells. Similar to
the observations in spontaneous Ca2 + transient, the ampli-
tude of the caffeine-induced Ca2 + from the cobalt chloride-
pretreated group was significantly higher compared with the
control group (Fig. 6F, approximately 2.4-fold increase;
p < 0.01). This finding suggests that sarcoplasmic reticulum
Ca2 + storage is increased in cardiomyocytes derived from
cobalt chloride-pretreated hES2 cells. In the kinetic analysis,
cardiomyocytes derived from cobalt chloride-pretreated
hES2 cells also displayed faster upstroke and decay velocities
during caffeine-induced Ca2 + transient (Fig. 6G and H). In
addition, application of 10 lM ryanodine significantly re-
duced the amount and release rate of intracellular calcium in
these cardiomyocytes, but not those from the control group
(Fig. 6I and J).
In cardiomyocytes, the sodium calcium exchanger
(NCX1), cardiac sarcoplasmic/endoplasmic reticulum cal-
cium ATPase (SERCA2A), and cardiac specific ryanodine
receptor (RYR2) are the key components that mediate cal-
cium transport (Graham et al., 2004). Calsequestrin (CaSQ),
triadin, and junctin play a role in regulating the sarcoplas-
mic reticulum function via their binding to RYR2 (Bers,
2004; Fan et al., 2008; Knollmann, 2009). Real-time quanti-
tative PCR analysis revealed that the expression of SER-
CA2A (3.6-fold, p < 0.05), RYR2 (4.1-fold, p < 0.05), and
triadin (2.5-fold, p < 0.05) was significantly increased in EBs
derived from the cobalt chloride-pretreated hES2 cells
compared with control cells (Fig. 7). Nevertheless, there
was no significant change in the mRNA level of NCX1,
CaSQ, or junctin in the two groups. These findings suggest
that improved sarcoplasmic reticulum function of cardio-
myocytes derived from cobalt chloride-pretreated hES2
cells is likely related to increased expression of the Ca2 + -
handling components.
FIG. 3. Effect of cobalt chloride
pretreatment on the cardiac
differentiation of hES2 human ESCs.
(A) The undifferentiated hES2 cells
were cultured for 72 h in the presence
or absence of 50 [M cobalt chloride
(CoCl2)] followed by cardiac
differentiation. The resulting embryoid
bodies (EBs) were allowed to attach
onto gelatin-coated plates and the
occurrence of beating EBs were
observed and counted for 20 to 25 days
starting from the day of attachment.
(B) After the 25-day period of cardiac
differentiation, the EBs were collected
for RNA isolation and the expressions
of cardiac specific markers, MHC-A,
MHC-B, and MLC2V between the
control and cobalt chloride-pretreated
groups were compared by real-time
quantitative PCR analysis. (C) Flow
cytometry analysis of sarcomeric
actinin-positive cells. Results are
presented in mean – SEM from at least
three independent experiments, where
*p< 0.05 and **p < 0.005 compared to
the control groups.
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Discussion
Our recent study has demonstrated that the cardiac dif-
ferentiation and maturation of murine ESCs can be promoted
by exogenous expression of the full-length HIF-1a cDNA
under a constitutive EF1a promoter (Ng et al., 2010). These
observations highlight the potential importance of the
HIF-1a subunit in directing cultured ESCs to differentiate into
more mature cardiomyocytes. Nevertheless, the therapeutic
application of this strategy is limited by the requirement of a
viral vector. The present study aimed to evaluate the use of
cobalt chloride-induced HIF-1a stabilization to promote cardiac
differentiation of cultured human ESCs. The use of divalent
ions (such as cobalt, iron, or nickel compounds) has a potential
advantage over the reduced oxygen tensions required in sta-
bilizing the HIF-1a subunit. First, the substantial cost involved
in the setup and operation of a reduced oxygen culture system
is avoided. Second, the use of a pharmacological treatment that
includes the defined concentration of drugs or chemicals is also
anticipated to provide more robust and reproducible results
between different laboratories. This is especially important gi-
ven that the actual partial pressure of oxygen that cells expe-
rience may differ widely among different culture setups and
sources of gas. As shown in this study, treatment of undiffer-
entiated hES2 human ESCs with cobalt chloride for 3 days was
associated with remarkably increased protein levels of HIF-1a.
Although increased HIF-1a expression was also observed in
cells cultured under reduced oxygen conditions, a decrease in
cell viability was also evident in this study. In contrast, previous
studies showed that reduced low oxygen tension can enhance
the culture and maintenance of H1 human ESCs in undiffer-
entiated states (Ezashi et al., 2005). The reasons for this dis-
crepancy remain unclear, but may be related to different ESC
lines and culture systems. In this study, the HES2 human ESC
line was cultured in a feeder-free serum-free culture system.
Previous studies (Ezashi et al., 2005) have used a mouse em-
bryonic fibroblast as feeder layer supplemented with 20%
KnockOut serum replacer to culture H1 human ESC line.
In this study, cobalt chloride pretreatment notably in-
creased the occurrence of beating EBs as well as expression of
cardiac specific structure components (MHC-A, MHC-B, and
MLC2V) over the 25-day period of cardiac differentiation
compared with controls. As cardiac differentiation of ESCs
was performed in the absence of cobalt chloride, it is rea-
sonable to speculate that cobalt chloride help initiate the
early cardiac differentiation process before embryoid body
formation, and this could be evidenced by the down-
regulation of the pluripotent markers (OCT4, SOX2, and
NANOG), and the upregulation of early cardiac differentia-
tion factors Nkx2.5, VEGF, and notably CT1 gene expression
during the pretreatment period. It is interesting that the ex-
pression of NGN, an early neuron-specific marker, was also
significantly increased after cobalt chloride treatment, while
the expressions of the skeletal muscle specific (MYOG) and
hematopoietic markers (GATA1 and SPI1) shows no signif-
icant difference. The reasons account for such observation is
not clear but deserve further investigation that would be out
of the scope of the present study.
HIF-1a plays an important role in the embryonic heart
development (Iyer et al., 1998; Nagao et al., 2008; Ramirez-
Bergeron and Simon, 2001), yet the direct action of HIF-1a on
the promoters of many cardiac genes remains to be
FIG. 4. Immunohistochemistry of hES2-derived cardio-
myocytes. (A) Individual cardiomyocytes was isolated from
the beating area of the EBs were paraformaldehyde fixed and
stained with the cardiomyocytes specific markers cardiac
troponin-T and sarcomeric actinin. Lower panel represent
the enlarged view of the area of interest (squared region).
Scale bar = 25 lmM. (B) the length to width ratio of cardiac
troponin-T and sarcomeric actinin positive cells. Results are
presented as mean – SEM from the measurement of 25 to 30
cells from each groups, where **p< 0.005 compared to the
control groups.
COCL2 PROMOTES CARDIAC DIFFERENTIATION OF HESCS 533
determined. Recently, Nagao et al. (2008) described that the
knockdown of HIF-1a causes significant reduction in the
nkx2.5 expression in a Xenopusmodel (Nagao et al., 2008) and
this may explain, in part, our observations that cobalt chloride
increase NKX2.5 expression in the undifferentiated hES2 cells.
The importance of VEGF and CT1 in the mediation of
cardiac differentiation from pluripotent stem cells has been
highlighted in various studies (Ateghang et al., 2006; Chen
et al., 2006; Xinyun et al., 2010). The appearance of a pop-
ulation of kinase insert domain protein receptor (KDR)-
positive progenitor cells during the very initial period of
differentiation dictates the subsequent cardiac differentiation
events of the ESCs (Yang et al., 2008). Accordingly, increased
expression of VEGF during cobalt chloride pretreatment may
play a role in activation of the KDR-positive cardiac pro-
genitor cells to increase the occurrence of beating EBs and the
percentage of sarcoplasmic actinin-positive cardiomyocytes.
It should be noted that attempts have been made to sup-
plement cobalt chloride throughout the whole differentiation
period, but such an approach appears to reduce the number
of beating EBs (data not shown). The underlying reason is
unclear but may be related to the oxidative toxicity that
arises from prolonged cobalt chloride treatment.
When the cobalt chloride-pretreated groups was com-
pared with the control group, the former showed a notable
increase not only in the differentiation of atrial- and nodal-
like cardiomyocytes, but also the maximum rise of the action
potential upstroke (dV/dtmax). Such a significant increase in
the dV/dtmax reflects an improved electrical maturity after
cobalt chloride treatment. Nonetheless, the limited sample
size means further work is required to identify whether
cobalt chloride pretreatment determines the fate of cadio-
myogenesis. In addition to these electrophysiological
observations, calcium homeostasis of the hES2-derived car-
diomyocytes was also studied. Those derived from the cobalt
chloride-pretreated group exhibited significant increases in
the amplitude, upstroke rate, and decay rates of the calcium
transient compared with the control group. This indicates
FIG. 5. (A) Cell-type
distribution and the
corresponding representative
action potential tracings of
the cardiomyocytes derived
from control (left panel) and
cobalt-pretreated (right panel)
hES2 cells. Action potentials
at 90% (APD90s) and 50%
(APD50s) repolarization (B,
C), maximal action potential
(AP) upstroke (D) and the
maximal diastolic potentials
(MPDs) (E) of hES2-derived
cardiomyocytes from
control (six cells) and cobalt
chloride-pretreated groups
(24 cells). Results are
presented as mean– SEM
(*p < 0.05; **p< 0.005).
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that the former may more effectively handle the release
and reuptake of intracellular calcium during excitation-
contraction coupling. In addition, the increased performance
of caffeine-induced calcium transient and increased ryano-
dine sensitivity in the cobalt chloride-pretreated cells suggests
these cardiomyocytes have improved sarcoplasmic reticulum
function. This assumption was further supported by the ob-
servation that both SERCA2A and RYR2, the two key com-
ponents that mediate the sequestration and release of calcium
from the sarcoplasmic reticulum, respectively, were signifi-
cantly upregulated in the cobalt chloride-pretreated cells. In
addition to SERCA2A and RYR2, the expression of RYR2
regulatory components dictates the maturity of the ESC-de-
rived cardiomyocytes (Liu et al., 2007, 2009). Although there
was no observable change in the expression of CaSQ and
junctin between the two groups, a significant increase in the
mRNA levels of triadin was also found in the cobalt chloride-
pretreated group: this might contribute to the improved sar-
coplasmic reticulum-mediated calcium transient in the treated
cells. With increasing evidence of the importance of sarco-
plasmic reticulum calcium load and transient in contractile
function of ESC-derived cardiomyocytes (Fu et al., 2006;
FIG. 7. The expression of calcium-handling components in
cardiomyocytes. The mRNA levels of calcium-handling
components NCX1, SERCA2A, RYR2, CaSQ, Triadin, and
Junctin in the EBs derived from the control or hES2 cells
pretreated with 50lM cobalt chloride (CoCl2) were evalu-
ated by real-time quantitative PCR analysis using GATA4 as
an internal reference. Data shown as mean– SEM from at
least three independent experiments; *P < 0.05.
FIG. 6. (A) Representative tracings of rhythmic spontane-
ous Ca2 + transients showing in cardiomyocytes derived
from the control and cobalt-pretreated hES2 cells. (B) Am-
plitude. (C) Maximal upstroke velocity (Vmax upstroke). (D)
Maximal decay velocity (Vmax decay) of Ca
2 + transients in
the hES2-derived cardiomyocytes. (E) Representative trac-
ings of caffeine-induced Ca2 + release from sarcoplasmic re-
ticulum in the cardiomyocytes derived from the control and
cobalt-pretreated hES2 cells, demonstrating caffeine-sensitive
Ca2 + stores and fractional release of total sarcoplasmic re-
ticulum Ca2 + load. (F) Amplitude. (G) Maximal upstroke
velocity (Vmax upstroke). (H) Maximal decay velocity (Vmax
decay) of Ca2 + transients in the hES2-derived cardiomyo-
cytes. Effects of ryanodine on the calcium release (I, J), the
amplitude (I), and maximal upstroke velocity (J) of sponta-
neous calcium transients from individual cardiomyocytes
were recorded in the absence or presence of 10 lM ryano-
dine. The percentage of amplitudes and Vmax upstroke val-
ues under ryanodine application to the corresponding values
recorded under ryanodine-free conditions were showed in
the right panels. Data shown as mean – SEM from the re-
cordings of 20 to 25 cells/cell clusters from three to five in-
dependent experiments (*p < 0.05; **p < 0.005).
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Liu et al., 2007), it has become clear that the proper calcium-
handling property of the ESC-derived cardiomyocytes is
crucial to functional integration of the transplanted cells into
the host tissue (Liu et al., 2007).
In conclusion, our present study provides evidence that
cobalt chloride-induced HIF-1a stabilization facilitates the
cardiac differentiation of human ESCs in a serum- and
feeder-free system. Unlike low oxygen culture systems, no
sophisticated or costly facilities are required, and there is no
reduction in viability of cobalt chloride-treated human ESCs.
Cardiomyocytes derived from cobalt chloride-treated cells
also appear to have a more advanced calcium-handling
ability. This may be due to increased expression of the sar-
coplasmic reticulum calcium-handling components. These
data provide a novel strategy to encourage maturation of
calcium handling of cardiomyocytes from ESCs for thera-
peutic application.
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